Brief: Allovir Reports Third Quarter 2021 Financial Results
05/11/2021 12:29
Nov 5 (Reuters) - Allovir Inc ALVR.O :
* ALLOVIR REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.72
Source text for Eikon: ID:nBw5S1LCHa
Further company coverage: ALVR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million